Hemophagocytic lymphohistiocytosis · Hämophagozytische Lymphohistiozytose · Macrophage activation syndrome · MAS · Haemophagocytic syndrome
Hemophagocytic syndrome is a severe disorder of the immune system where the body's defense cells abnormally activate and begin destroying its own healthy blood cells, including red blood cells, white blood cells, and platelets. This destructive process primarily occurs in the spleen, bone marrow, and liver, leading to a critical shortage of vital blood components.
Owners may notice sudden and severe weakness, high fever, pale gums, and tiny purple or red spots on the skin or gums caused by bleeding. These symptoms typically develop rapidly.
This condition requires immediate, intensive medical stabilization, including immunosuppressive therapy and potentially blood transfusions. Treatment is highly intensive and typically costs between €2,000 and €7,000, though the long-term prognosis is often guarded.
Estimated range of typical treatment cost. Actual cost depends on severity, clinic and region.
More conditions affecting the General / metabolic.